Anti-Tubercular Treatment Schedule for Spinal Tuberculosis

Standard Regimen Components

The standard treatment regimen for drug-susceptible spinal tuberculosis consists of 2 months of isoniazid, rifampicin, pyrazinamide, and ethambutol, followed by 4 months of isoniazid and rifampicin, for a total duration of 6 months, as recommended by the European Respiratory Journal and Thorax 1, 2
Isoniazid should be administered at a dose of 5 mg/kg daily or 15 mg/kg thrice weekly, as recommended by Clinical Infectious Diseases 4, 5
Rifampicin should be administered at a dose of 10 mg/kg daily or 10 mg/kg thrice weekly, as recommended by Clinical Infectious Diseases 4, 5
Pyrazinamide should be administered at a dose of 15-30 mg/kg daily or 50-70 mg/kg twice weekly, as recommended by Clinical Infectious Diseases 4
Ethambutol should be administered at a dose of 15-25 mg/kg daily or 50 mg/kg twice/thrice weekly, as recommended by Clinical Infectious Diseases 4, 5

For children with spinal tuberculosis, treatment should be extended to 12 months rather than the standard 6 months, as recommended by Thorax 2
If spinal cord compression is present, adjuvant corticosteroids should be added during the first 6-8 weeks, as recommended by the European Respiratory Journal 1

Pyridoxine supplementation should be added to all patients receiving isoniazid who have diabetes, HIV infection, malnutrition, chronic renal failure, alcoholism, pregnancy, or advanced age, as recommended by Clinical Infectious Diseases and Praxis Medical Insights 4, 5, 3
Liver function tests should be monitored at baseline and if symptoms develop, and rifampicin, isoniazid, and pyrazinamide should be stopped immediately if AST/ALT rises to 5 times normal or bilirubin rises, as recommended by Thorax 6

Directly Observed Therapy (DOT) is strongly recommended for all tuberculosis patients to ensure adherence and prevent drug resistance, as recommended by the European Respiratory Journal and Clinical Infectious Diseases 1, 4
Daily dosing is preferred over intermittent dosing when feasible, though 5-days-a-week DOT is an acceptable alternative to 7-days-a-week administration, as recommended by Clinical Infectious Diseases 4, 5

Pyrazinamide should not be used beyond 2 months in the standard regimen, as prolonged use increases hepatotoxicity risk without additional benefit, as recommended by Clinical Infectious Diseases 4
Ethambutol should not be omitted in the initial phase unless drug susceptibility is confirmed and primary isoniazid resistance is less than 4% in the community, as recommended by the European Respiratory Journal and Clinical Infectious Diseases 1, 4
Treatment duration should not be extended routinely to 9-12 months for spinal TB in adults without specific indications, as 6 months is effective for most cases, as recommended by Thorax 2